PL3178807T3 - Lipid kationowy - Google Patents
Lipid kationowyInfo
- Publication number
- PL3178807T3 PL3178807T3 PL15829025T PL15829025T PL3178807T3 PL 3178807 T3 PL3178807 T3 PL 3178807T3 PL 15829025 T PL15829025 T PL 15829025T PL 15829025 T PL15829025 T PL 15829025T PL 3178807 T3 PL3178807 T3 PL 3178807T3
- Authority
- PL
- Poland
- Prior art keywords
- cationic lipid
- lipid
- cationic
- Prior art date
Links
- -1 Cationic lipid Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
- C07C229/12—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of acyclic carbon skeletons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/34—Esters of acyclic saturated polycarboxylic acids having an esterified carboxyl group bound to an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
- C11C3/00—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
- C11C3/003—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fatty acids with alcohols
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/30—Special therapeutic applications
- C12N2320/32—Special delivery means, e.g. tissue-specific
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Wood Science & Technology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Physics & Mathematics (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Optics & Photonics (AREA)
- Nanotechnology (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Dispersion Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014161718 | 2014-08-07 | ||
| EP15829025.4A EP3178807B1 (en) | 2014-08-07 | 2015-08-06 | Cationic lipid |
| PCT/JP2015/072344 WO2016021683A1 (ja) | 2014-08-07 | 2015-08-06 | カチオン性脂質 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3178807T3 true PL3178807T3 (pl) | 2020-08-24 |
Family
ID=55263940
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL15829025T PL3178807T3 (pl) | 2014-08-07 | 2015-08-06 | Lipid kationowy |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US10252974B2 (pl) |
| EP (1) | EP3178807B1 (pl) |
| JP (1) | JP6587619B2 (pl) |
| KR (1) | KR101882634B1 (pl) |
| CN (1) | CN106573877B (pl) |
| AU (1) | AU2015300046B2 (pl) |
| CA (1) | CA2956554C (pl) |
| ES (1) | ES2799409T3 (pl) |
| IL (1) | IL250236B (pl) |
| PL (1) | PL3178807T3 (pl) |
| SG (1) | SG11201700828PA (pl) |
| WO (1) | WO2016021683A1 (pl) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5645840B2 (ja) | 2008-12-02 | 2014-12-24 | 株式会社Wave Life Sciences Japan | リン原子修飾核酸の合成方法 |
| IN2012DN00720A (pl) | 2009-07-06 | 2015-06-19 | Ontorii Inc | |
| US10428019B2 (en) | 2010-09-24 | 2019-10-01 | Wave Life Sciences Ltd. | Chiral auxiliaries |
| RU2014105311A (ru) | 2011-07-19 | 2015-08-27 | Уэйв Лайф Сайенсес Пте. Лтд. | Способы синтеза функционализованных нуклеиновых кислот |
| SG11201500239VA (en) | 2012-07-13 | 2015-03-30 | Wave Life Sciences Japan | Asymmetric auxiliary group |
| KR102423317B1 (ko) | 2014-01-16 | 2022-07-22 | 웨이브 라이프 사이언시스 리미티드 | 키랄 디자인 |
| CN107427531A (zh) | 2015-03-24 | 2017-12-01 | 协和发酵麒麟株式会社 | 含有核酸的脂质纳米粒子 |
| GB201604235D0 (en) * | 2016-03-11 | 2016-04-27 | Ucl Business Plc | Lipids and complexes for the delivery of biologically-active material to cells |
| CN118512596A (zh) | 2017-12-27 | 2024-08-20 | 武田药品工业株式会社 | 含核酸脂质纳米粒子及其用途 |
| WO2019131829A1 (ja) | 2017-12-28 | 2019-07-04 | 国立大学法人京都大学 | 標的遺伝子改変用組成物 |
| CN111511713B (zh) | 2017-12-28 | 2024-01-02 | 武田药品工业株式会社 | 阳离子性脂质 |
| TWI851592B (zh) * | 2018-08-10 | 2024-08-11 | 國立大學法人京都大學 | 使用陽離子性脂質對心肌細胞進行轉染的方法 |
| EP3835287B1 (en) * | 2018-08-10 | 2024-10-02 | Takeda Pharmaceutical Company Limited | Cationic lipid |
| WO2020080475A1 (ja) * | 2018-10-18 | 2020-04-23 | 武田薬品工業株式会社 | T細胞の活性化/増殖方法 |
| WO2022045334A1 (ja) | 2020-08-31 | 2022-03-03 | 武田薬品工業株式会社 | 推論装置、推論方法、推論プログラム、モデル生成方法、推論サービス提供システム、推論サービス提供方法及び推論サービス提供プログラム |
| CZ2020529A3 (cs) * | 2020-09-23 | 2022-03-30 | Ăšstav organickĂ© chemie a biochemie AV ÄŚR, v. v. i. | Lipidoidy pro transfekci nukleových kyselin a jejich použití |
| CN115197079A (zh) * | 2021-04-08 | 2022-10-18 | 厦门赛诺邦格生物科技股份有限公司 | 一种聚乙二醇化脂质及其修饰的脂质体、含该脂质体的药物组合物及其制剂和应用 |
| AR127615A1 (es) | 2021-11-10 | 2024-02-14 | Takeda Pharmaceuticals Co | Lípido catiónico |
| US20250191703A1 (en) | 2022-02-28 | 2025-06-12 | Takeda Pharmaceutical Company Limited | Inference device, generation device, inference program, and generation program |
| CN115850135B (zh) * | 2022-04-29 | 2023-11-21 | 喻国灿 | 含硫Janus型可离子化脂质体及其用途 |
| EP4630561A1 (en) | 2022-12-09 | 2025-10-15 | Takeda Pharmaceutical Company Limited | Modified immunomodulators |
| CN121358499A (zh) | 2023-03-30 | 2026-01-16 | Ose免疫疗法 | 靶向活化的免疫细胞以表达免疫细胞增强分子的基于脂质的纳米粒及其用途 |
| CN121335715A (zh) | 2023-03-30 | 2026-01-13 | Ose免疫疗法 | 靶向性脂质纳米粒的合成方法及其用途 |
| TW202449142A (zh) | 2023-04-07 | 2024-12-16 | 日商武田藥品工業股份有限公司 | 接合複合物 |
| WO2024236361A1 (en) | 2023-05-15 | 2024-11-21 | Takeda Pharmaceutical Company Limited | Compositions and methods for delivery of nucleic acids to cells |
| WO2024236504A1 (en) | 2023-05-15 | 2024-11-21 | Takeda Pharmaceutical Company Limited | Sequences and methods for delivery of dna and rna |
| WO2024249954A1 (en) | 2023-05-31 | 2024-12-05 | Capstan Therapeutics, Inc. | Lipid nanoparticle formulations and compositions |
| WO2025027116A1 (en) | 2023-08-01 | 2025-02-06 | Institut Curie | Nanoparticles comprising nucleic acid sequences encoding cyclic gmp-amp synthase |
| WO2025133115A1 (en) | 2023-12-21 | 2025-06-26 | Ose Immunotherapeutics | Lipid-based nanoparticles comprising il-35 |
| WO2025178465A1 (ko) * | 2024-02-19 | 2025-08-28 | 주식회사 메디치바이오 | 신규한 이온화 지질 및 이를 이용한 지질 나노입자 조성물 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6043390A (en) | 1998-04-03 | 2000-03-28 | The Regents Of The University Of California | Pentaerythritol lipid derivatives and nucleic-acid complexes |
| ES2336766T3 (es) * | 2000-10-04 | 2010-04-16 | Kyowa Hakko Kirin Co., Ltd. | Procedimiento de recubrimiento de particulas finas con pelicula lipidica. |
| WO2003102150A2 (en) * | 2002-05-31 | 2003-12-11 | Genteric, Inc. | Multi-functional polyamines for delivery of biologically-active polynucleotides |
| JP2009023972A (ja) * | 2007-07-23 | 2009-02-05 | Fujifilm Corp | ジエチレントリアミン型金属キレート構造を有する分岐鎖高級脂肪酸トリエステル誘導体 |
| KR102264822B1 (ko) | 2008-11-10 | 2021-06-14 | 알닐람 파마슈티칼스 인코포레이티드 | 치료제 운반용 신규 지질 및 조성물 |
| CN101780286A (zh) * | 2009-01-16 | 2010-07-21 | 中国人民解放军总医院 | 趋化因子受体cxcr4非肽类拮抗剂的放射性诊断与治疗药物 |
| KR101773643B1 (ko) | 2010-04-28 | 2017-08-31 | 교와 핫꼬 기린 가부시키가이샤 | 양이온성 지질 |
| DK3254672T3 (en) | 2010-06-03 | 2025-11-03 | Alnylam Pharmaceuticals Inc | Biodegradable lipids for the delivery of active agents |
| JP2013545727A (ja) | 2010-10-21 | 2013-12-26 | メルク・シャープ・アンド・ドーム・コーポレーション | オリゴヌクレオチド送達用の新規低分子量カチオン性脂質 |
| DE21212055T1 (de) | 2011-12-07 | 2022-08-04 | Alnylam Pharmaceuticals, Inc. | Biologisch abbaubare lipide zur freisetzung von wirkstoffen |
| US9463247B2 (en) | 2011-12-07 | 2016-10-11 | Alnylam Pharmaceuticals, Inc. | Branched alkyl and cycloalkyl terminated biodegradable lipids for the delivery of active agents |
| CN104321304A (zh) | 2012-02-24 | 2015-01-28 | 普洛体维生物治疗公司 | 三烷基阳离子脂质及其使用方法 |
| CN102898549A (zh) * | 2012-10-09 | 2013-01-30 | 长沙新宇高分子科技有限公司 | 高支化的大分子光引发剂及其制备方法 |
-
2015
- 2015-08-06 PL PL15829025T patent/PL3178807T3/pl unknown
- 2015-08-06 EP EP15829025.4A patent/EP3178807B1/en active Active
- 2015-08-06 ES ES15829025T patent/ES2799409T3/es active Active
- 2015-08-06 CA CA2956554A patent/CA2956554C/en active Active
- 2015-08-06 AU AU2015300046A patent/AU2015300046B2/en active Active
- 2015-08-06 WO PCT/JP2015/072344 patent/WO2016021683A1/ja not_active Ceased
- 2015-08-06 US US15/502,063 patent/US10252974B2/en active Active
- 2015-08-06 KR KR1020177006133A patent/KR101882634B1/ko active Active
- 2015-08-06 JP JP2016540736A patent/JP6587619B2/ja active Active
- 2015-08-06 SG SG11201700828PA patent/SG11201700828PA/en unknown
- 2015-08-06 CN CN201580042288.1A patent/CN106573877B/zh active Active
-
2017
- 2017-01-23 IL IL250236A patent/IL250236B/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| CN106573877B (zh) | 2021-04-13 |
| AU2015300046A1 (en) | 2017-02-16 |
| KR101882634B1 (ko) | 2018-07-26 |
| JPWO2016021683A1 (ja) | 2017-06-08 |
| CN106573877A (zh) | 2017-04-19 |
| CA2956554C (en) | 2022-03-01 |
| IL250236A0 (en) | 2017-03-30 |
| KR20170039722A (ko) | 2017-04-11 |
| EP3178807A1 (en) | 2017-06-14 |
| IL250236B (en) | 2021-04-29 |
| AU2015300046B2 (en) | 2019-05-09 |
| WO2016021683A1 (ja) | 2016-02-11 |
| US20170197903A1 (en) | 2017-07-13 |
| ES2799409T3 (es) | 2020-12-17 |
| EP3178807B1 (en) | 2020-04-29 |
| SG11201700828PA (en) | 2017-03-30 |
| EP3178807A4 (en) | 2018-03-28 |
| US10252974B2 (en) | 2019-04-09 |
| JP6587619B2 (ja) | 2019-10-09 |
| CA2956554A1 (en) | 2016-02-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL250236B (en) | cationic fat | |
| GB201707959D0 (en) | No details | |
| EP3252043A4 (en) | Cationic lipid | |
| EP3239132A4 (en) | Cationic lipid | |
| GB201517022D0 (en) | No details | |
| GB201410907D0 (en) | No details | |
| GB201519531D0 (en) | No details | |
| GB201517404D0 (en) | No details | |
| GB201706130D0 (en) | No details | |
| GB201418217D0 (en) | No details | |
| GB201418216D0 (en) | No details | |
| GB201615071D0 (en) | No details | |
| EP3093283A4 (en) | Cationic lipid | |
| GB201612542D0 (en) | no details | |
| GB201516796D0 (en) | No details | |
| GB201517412D0 (en) | No details | |
| GB201517574D0 (en) | No details | |
| GB201709180D0 (en) | No details | |
| EP3162794A4 (en) | Cationic lipid | |
| GB201616225D0 (en) | No details | |
| GB201708207D0 (en) | No details | |
| GB201517605D0 (en) | No details | |
| GB2523362B (en) | Turbogenerator | |
| GB201702336D0 (en) | No details | |
| GB201410910D0 (en) | No details |